BioPorto (BIOPOR.CO)

Nasdaq Copenhagen · Financial statements, TTM figures and earnings dates

In fiscal year 2025 (ended December 31, 2025), BioPorto reported revenue of DKK 40.3M and net income of −DKK 82.1M. Annual financial statements are available for fiscal years 2020 to 2025, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

DKK	FY2025 2025-12-31	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31
Income statement
Revenue	DKK 40.3M	DKK 36.2M	DKK 31.0M	DKK 29.0M	DKK 24.3M
Gross profit	DKK 30.4M	DKK 24.5M	DKK 20.2M	DKK 19.0M	DKK 15.0M
Operating income	−DKK 86.1M	−DKK 75.5M	−DKK 61.2M	−DKK 81.5M	−DKK 65.3M
Net income	−DKK 82.1M	−DKK 68.2M	−DKK 56.3M	−DKK 75.9M	−DKK 57.1M
Diluted EPS	−DKK 0.00	−DKK 0.00	−DKK 0.16	−DKK 0.24	−DKK 0.21
Cash flow
Operating cash flow	−DKK 77.1M	−DKK 83.6M	−DKK 55.5M	−DKK 52.5M	−DKK 64.6M
Capital expenditure	DKK 0	DKK 350.0K	DKK 39.0K	DKK 407.0K	DKK 130.0K
Free cash flow	−DKK 77.1M	−DKK 83.9M	−DKK 55.5M	−DKK 52.9M	−DKK 64.7M
Balance sheet
Cash and equivalents	DKK 54.9M	DKK 59.7M	DKK 66.4M	DKK 81.8M	DKK 45.5M
Total assets	DKK 93.2M	DKK 96.0M	DKK 89.8M	DKK 108.6M	DKK 81.3M
Total liabilities	DKK 30.2M	DKK 28.2M	DKK 29.7M	DKK 38.4M	DKK 35.3M
Shareholders' equity	DKK 63.0M	DKK 67.8M	DKK 60.1M	DKK 70.2M	DKK 46.0M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in DKK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full BIOPOR.CO page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open BIOPOR.CO financials →